Insulin aspart, recombinant Subcutaneous and Metoclopramide Injection Solution
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Metoclopramide Injection Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: metoclopramide
Brand name: Metozolv ODT, Reglan
Synonyms: Metoclopramide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Metoclopramide Intravenous
- Insulin aspart, recombinant Subcutaneous-Metoclopramide Oral Solution
- Insulin aspart, recombinant Subcutaneous-Metoclopramide oral/injection
- Insulin aspart, recombinant Subcutaneous-Metoclopramide Orally Disintegrating Tablets
- Insulin aspart, recombinant Subcutaneous-Metoclopramide Tablets
- Insulin aspart, recombinant Subcutaneous-Metolazone
- Metoclopramide Injection Solution-Insulin degludec
- Metoclopramide Injection Solution-Insulin Degludec (U-100) Prefilled Pens
- Metoclopramide Injection Solution-Insulin Degludec (U-100) Vials
- Metoclopramide Injection Solution-Insulin Degludec (U-200) Prefilled Pens
- Metoclopramide Injection Solution-Insulin degludec and liraglutide
- Metoclopramide Injection Solution-Insulin degludec and liraglutide Subcutaneous